Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page
- Check5 days agoChange DetectedThe Record History now shows a new revision (v3.5.2) and removes an older revision (v3.5.0) from the version list.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedNew revision entry v3.5.0 added to the study record history. Revision v3.4.3 removed.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision v3.4.3 was added to the Version History. Revision v3.4.2 was removed.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.4.2. Removed a government funding lapse notice and Revision: v3.4.1.SummaryDifference0.8%

- Check77 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check84 days agoChange DetectedShow glossary toggle added; UI legends explain color-coded additions (green) and deletions (red), and the revision label updated to v3.4.0. No core content changes occurred; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.